{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:37Z","timestamp":1707524317070},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,11]]},"DOI":"10.7759\/cureus.15594","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T14:11:13Z","timestamp":1623420673000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapidly Progressing Primary Membranous Nephropathy in a Hispanic Male With Elevated Levels of Anti-phospholipase A2 Receptor Antibodies"],"prefix":"10.7759","author":[{"given":"Hamza","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios G","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Gogia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diagnosis and management of nephrotic syndrome","volume":"261","author":"McCloskey O","year":"2017","unstructured":"McCloskey O, Maxwell AP. Diagnosis and management of nephrotic syndrome. Practitioner. 2017, 261:11-5.","journal-title":"Practitioner"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2014.11.002","article-title":"Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment","volume":"114","author":"Lai WL","year":"2015","unstructured":"Lai WL, Yeh TH, Chen PM, et al.. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. J Formos Med Assoc. 2015, 114:102-11. 10.1016\/j.jfma.2014.11.002","journal-title":"J Formos Med Assoc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck LH Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009, 361:11-21. 10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas NM","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al.. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014, 371:2277-87. 10.1056\/NEJMoa1409354","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.048","article-title":"Membranous nephropathy: integrating basic science into improved clinical management","volume":"91","author":"Cattran DC","year":"2017","unstructured":"Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 2017, 91:566-74. 10.1016\/j.kint.2016.09.048","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser WG","year":"2017","unstructured":"Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017, 12:983-97. 10.2215\/CJN.11761116","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-31802009000300006","article-title":"Glomerular diseases in a Hispanic population: review of a regional renal biopsy database","volume":"127","author":"Arias LF","year":"2009","unstructured":"Arias LF, Henao J, Giraldo RD, Carvajal N, Rodelo J, Arbel\u00e1ez M. Glomerular diseases in a Hispanic population: review of a regional renal biopsy database. Sao Paulo Med J. 2009, 127:140-4. 10.1590\/s1516-31802009000300006","journal-title":"Sao Paulo Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: comprehensive review and historical perspective","volume":"95","author":"Keri KC","year":"2019","unstructured":"Keri KC, Blumenthal S, Kulkarni V, Beck L, Chongkrairatanakul T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad Med J. 2019, 95:23-31. 10.1136\/postgradmedj-2018-135729","journal-title":"Postgrad Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5414\/cnp63001","article-title":"Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns","volume":"63","author":"Dragovic D","year":"2005","unstructured":"Dragovic D, Rosenstock JL, Wahl SJ, Panagopoulos G, DeVita MV, Michelis MF. Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol. 2005, 63:1-7. 10.5414\/cnp63001","journal-title":"Clin Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza FC","year":"2019","unstructured":"Fervenza FC, Appel GB, Barbour SJ, et al.. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019, 381:36-46. 10.1056\/NEJMoa1814427","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese AS","year":"2017","unstructured":"De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC. A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol. 2017, 28:421-30. 10.1681\/ASN.2016070776","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61533-rapidly-progressing-primary-membranous-nephropathy-in-a-hispanic-male-with-elevated-levels-of-anti-phospholipase-a2-receptor-antibodies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:30Z","timestamp":1707506670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61533-rapidly-progressing-primary-membranous-nephropathy-in-a-hispanic-male-with-elevated-levels-of-anti-phospholipase-a2-receptor-antibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.15594","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}